New biomarker may spot fetal alcohol brain damage early

NCT ID NCT03371641

Recruiting now Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a substance called PlGF in the umbilical cord and placenta can act as an early warning sign for brain damage in babies whose mothers drank alcohol during pregnancy. Researchers will compare PlGF levels between 60 pairs of mothers and babies—some with alcohol exposure and some without. The goal is to see if PlGF can help predict developmental problems that may appear when the child is 2 to 6 years old, allowing for earlier help and support.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FETAL ALCOHOL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal alcohol spectrum disorder fetal alcohol syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FETAL ALCOHOL SYNDROME

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

UH ROUEN
RECRUITING

Rouen, 76000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••